Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2008 1
2009 1
2010 1
2012 1
2015 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
The impact of interferon-alpha treatment on clinical and immunovirological aspects of HTLV-1-associated myelopathy in northeast of Iran.
Rafatpanah H, Rezaee A, Etemadi MM, Hosseini RF, Khorram B, Afsahr L, Taylor G, Mokhber N, Mahmoudi M, Abbaszadegan MR, Foroghipor M, Hashemi P, Amiri A, Tehrani M, Azarpazhooh A, Azarpazhooh MR. Rafatpanah H, et al. Among authors: etemadi mm. J Neuroimmunol. 2012 Sep 15;250(1-2):87-93. doi: 10.1016/j.jneuroim.2012.05.004. Epub 2012 Jun 23. J Neuroimmunol. 2012. PMID: 22727800 Clinical Trial.
Triple Therapy with Prednisolone, Pegylated Interferon and Sodium Valproate Improves Clinical Outcome and Reduces Human T-Cell Leukemia Virus Type 1 (HTLV-1) Proviral Load, Tax and HBZ mRNA Expression in Patients with HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.
Boostani R, Vakili R, Hosseiny SS, Shoeibi A, Fazeli B, Etemadi MM, Sabet F, Valizade N, Rezaee SA. Boostani R, et al. Among authors: etemadi mm. Neurotherapeutics. 2015 Oct;12(4):887-95. doi: 10.1007/s13311-015-0369-3. Neurotherapeutics. 2015. PMID: 26174324 Free PMC article.